Vancouver, British Columbia – March 8, 2019 – Orchid Ventures, Inc. (the "Company") announces that further to its press release of September 13, 2018, effective on March 7, 2019, it has completed the acquisition (the "Acquisition") of all of the issued and outstanding securities of CR International Inc., a Nevada corporation, ("CRI") pursuant to the terms of a securities exchange agreement dated September 12, 2018, as amended, (the "Definitive Agreement") among the Company, CRI and CR Companies, LLC., a limited liability company existing under the laws of the state of California, doing business as Orchid Essentials ("CRC" and together with CRI, "Orchid").

Pursuant to the Acquisition, the Company issued an aggregate of 39,364,852 common shares of the Company "(Shares") to the shareholders of CRI at a deemed price of $0.33 per Share and CRI became a wholly-owned subsidiary of the Company.

The Company also issued 629,200 common share purchase warrants (the "Warrants") to the warrantholders of CRI. Each Warrant entitles the holder thereof to purchase one Share at a price of $0.33 until March 18, 2020.

In addition, members of CRC who held exchangeable units of CRC ("Exchangeable Units") have the right to exchange such Exchangeable Units for Shares at any time until March 7, 2023. An aggregate of 62,142,857 Shares will be issued in connection with the exchange of Exchangeable Units. A voting trust ("Voting Trust") was established on closing, pursuant to which the co-trustees of such Voting Trust will be issued a special voting share in the capital of the Company (the "Special Voting Share") entitling them to vote a total of 62,142,857 Shares, which represents the total number of Shares to be issued by the Company in exchange for the Exchangeable Units. As Exchangeable Units are exchanged for Shares, the voting rights attached to the Special Voting Share will be cancelled proportionately to the number of Shares issued. As a result, and at the end of the four-year period allowed for exchanges, the Special Voting Share will be cancelled. Certain Shares to be issued to the principals of the Company upon exchange of the Exchangeable Units are subject to escrow conditions required by applicable securities laws and requirements of the Canadian Securities Exchange (the "CSE").

The Company issued 2,000,000 Shares to an arm’s length third party as a finder’s fee in connection with the Acquisition.

In conjunction with closing of the Acquisition, effective February 28, 2019 the Company changed its name from Earny Resources Ltd. to "Orchid Ventures, Inc."

In connection with the Acquisition, the Company closed a private placement on March 7, 2019 (the "Private Placement") consisting of 15,366,711 Shares at a price of $0.33 per Share for gross proceeds of $5,071,014.63.

Pursuant to the Private Placement, the Company paid aggregate finder’s fees of $172,297.19 and issued 203,350 common share purchase warrants (the "Finder Warrants"). Each Finder Warrant is exercisable for one Share at an exercise price $0.33 per Share until March 7, 2021.

All securities issued pursuant to the Private Placement are subject to a four-month hold period in accordance with applicable securities laws expiring July 8, 2019.

On February 8, 2019 the Company received CSE conditional approval of the Acquisition and the listing of its Shares on the CSE. Trading on the CSE under the symbol "ORCD" is expected to commence once final approval is obtained from the CSE. Further information regarding the listing date will be provided in a subsequent news release.

For further details on the Acquisition and the Private Placement please see the Listing Statement dated January 29, 2019 which was filed under the Company’s profile at www.sedar.com under the category "filing statement" on February 8, 2019.

The securities issued pursuant to the Acquisition and the Private Placement have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), and may not be offered or sold in the United States absent registration or applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities issued by the Company pursuant to the Acquisition and the Private Placement are "restricted securities" as defined under Rule 144(a)(3) of the U.S. Securities Act and contain the appropriate restrictive legends as required under the U.S. Securities Act and Canadian Securities Administrators National Instrument 45-102.

About Orchid

Orchid is an award-winning cannabis brand with THC and CBD product lines currently sold in 250+ dispensaries across California and Oregon. Orchid plans to expand its brand into new markets such as Nevada, New York, Puerto Rico, Canada and other global markets. With a continued focus on brand and intellectual property development, Orchid will execute strategic acquisitions to solidify an integrated cannabis manufacturing and distribution infrastructure with the goal of becoming a dominant premium cannabis brand in the United States. Orchid's management brings significant branding, product development, manufacturing, and distribution experience with a proven track record of scaling revenues, building value generating partnerships, and creating enterprise value.

ON BEHALF OF THE BOARD of DIRECTORS

Orchid Ventures, Inc.

"Corey Mangold"

Corey Mangold,
Director

For further information please contact:

Karan Thakur
karan@vashneycapital.com
Tel: 778-987-3446

Cautionary Statement

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively "forward-looking statements"). The use of any of the word "will" and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon.. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.